Contact
Please use this form to send email to PR contact of this press release:
Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with Diabetic Macular Edema
TO:
Please use this form to send email to PR contact of this press release:
Adverum Biotechnologies Provides Update on the INFINITY Trial Evaluating ADVM-022 in Patients with Diabetic Macular Edema
TO: